Non-Hodgkins Lymphoma
Kite cues up first EMA okay for mantle cell lymphoma CAR-T
Phil Taylor
CHMP, ema, Gilead Sciences, Kite Pharma, mantle cell lymphoma, Non-Hodgkins Lymphoma
0 Comment
News/ News/ News/ Oncology/ Patients
Real-world data backs Kymriah’s safety profile, says Novartis
Phil Taylor
acute lymphoblastic leukaemia, Haematology, Kymriah, Non-Hodgkins Lymphoma, Novartis, real world data
0 Comment
Early data from Roche’s NHL drug mosunetuzumab steals the show at ASH
Richard Staines
cancer, Non-Hodgkins Lymphoma, Roche
0 Comment
Celgene bags FDA okay for Revlimid combo in lymphoma
Phil Taylor
Celgene, Non-Hodgkins Lymphoma, Revlimid, Rituxan
0 Comment
EU approves Kyowa Kirin’s drug for rare lymphoma
Joy Persaud
cancer, Kyowa Kirin, Non-Hodgkins Lymphoma
0 Comment
Celltrion/Teva Rituxan biosimilar edges closer to US approval
Richard Staines
cancer, Celltrion, Non-Hodgkins Lymphoma, Roche, Teva
0 Comment
Great news for Kite after CAR-T success in cancer patients
Andrew McConaghie
CAR T, Kite Pharma, NHL, Non-Hodgkins Lymphoma
0 Comment